BridgeMD
New treatment option for Pain
Official title The Effect of Storigami Method on Pain, Fear and Anxiety Levels Associated With Peripheral Intravenous Catheterisation in Children
ClinicalTrials.gov ID: NCT07009028
What this study is testing
What is Storigami figure?
Storigami figure is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for pain.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The aim of this study was to determine the effect of storigami method on reducing pain, fear and anxiety of children in peripheral intravenous catheter applications in children aged 6-9 years who were hospitalized in the pediatric health and diseases clinic.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 9. Healthy volunteers may be eligible.
You may be able to join if
- Volunteering to participate in the study
- The child is between 6-9 years old
- First time peripheral intravenous catheter insertion since admission to the clinic
- The child has no vision, hearing and speech problems
- The child has no mental retardation
You likely can't join if
- The child has a chronic, congenital, metabolic or neurodegenerative disease
- Failed attempt at peripheral intravenous catheterization,
- Failure to complete or incomplete completion of questionnaires,
- A different invasive intervention was performed immediately before PIC application,
- The child does not comply during the procedure,
- The child wants to leave the study
See the full eligibility criteria
- Volunteering to participate in the study
- The child is between 6-9 years old
- First time peripheral intravenous catheter insertion since admission to the clinic
- The child has no vision, hearing and speech problems
- The child has no mental retardation
- Know/speak Turkish
- No complaints such as pain, nausea and vomiting that may affect fear and anxiety
- No sedative or analgesic was given to the child immediately before the peripheral intravenous catheterization procedure
- The child has a chronic, congenital, metabolic or neurodegenerative disease
- Failed attempt at peripheral intravenous catheterization,
- Failure to complete or incomplete completion of questionnaires,
- A different invasive intervention was performed immediately before PIC application,
- The child does not comply during the procedure,
- The child wants to leave the study
The study team makes the final eligibility decision.
Where it's taking place
- Izmir, Bornova, Turkey (Türkiye)
- Izmir, İzmir, Turkey (Türkiye)
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 9 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Izmir, Bornova, Turkey (Türkiye); Izmir, İzmir, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.